About Us
We conduct research on point-of-care products the way it should be: fast, structured, and independent.
Diagnoodle is an independent information platform for professional point-of-care in-vitro diagnostics. It supports medical professionals in comparing POCT devices in a structured way and making informed decisions – digitally, evidence-based and practically oriented.
Advantages
We conduct research on point-of-care products the way it should be: fast, simple and independent.
Market overview instead of individual research
Targeted filters enable quick orientation in the POCT market.
Studies and product documentation
Studies and product materials collected in one place to support evidence-based decision-making.
Customized comparison reports
Simple comparison of product features for faster identification of similarities and differences.
Practice-oriented application videos
Application videos produced according to the Diagnoodle standard to reflect real-world workflows. Available for selected products from transparency partners.
AI product assistant
Receive immediate, 24/7 answers to your questions for selected products from transparency partners.
Direct request for quotation
Receive your personalized offer in the shortest possible time. We ensure a response from the respective seller.
Who is Diagnoodle for?
For anyone who works with point-of-care testing (POCT), for example
Clinics
Emergency services
Private practice physicians
Pharmacies
Product catalog
Use our extensive product database to find the best solution for your application.
Blutzucker
Blutgasanalyse
Hämatologie
Molekulardiagnostik
Gerinnung
Andere Produkte
Cooperation partners & Users
Through exchange with professional societies and users from purchasing, laboratory, medical technology and many other areas, we ensure the practical development of our product range.
Transparency partner
These companies participate as part of a paid partnership and provide additional, transparent product information. To maintain its independence, Diagnodo does not receive any share of the generated revenue.
moreAbout Us
Discover the latest news and updates.
